Personalis Reports First Quarter Results and Recent Highlights
Personalis reported Q1 clinical test volume surged 258% year-over-year to 7,815 tests, driven by the adoption of its NeXT Personal test and supported by new Medicare coverage for lung cancer surveillance. Total revenue declined to $15.5 million from $20.6 million year-over-year, reflecting a strategic shift away from non-core revenue streams towards its MRD business.
Key figures
- Revenue
- 15472000
- Guidance
- FY2026 Total revenue $78.0-$80.0M; Clinical revenue $10.0-$11.0M (5x growth); Net loss ~$105.0M
- Net loss
- 30000000
- Cash position
- 233200000
- Clinical revenue
- 1400000
- Clinical volume yoy
- 258%
- Clinical test volume
- 7815
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.